In-office ancillary services are growing at a rapid pace, and the increased utilization may require narrowing the exception for such services under the physician self-referral law, as well as altering the payment system, the Medicare Payment Advisory Commission (MedPAC) said at a public meeting Jan. 15.
The two largest diagnostic imaging chains are positioning themselves to take advantage of anticipated consolidation in the industry over the next few years.
Despite a few problem areas regarding access, most Medicare beneficiaries still are able to receive office care, according to the Medicare Payment Advisory Commission, which recommended Jan. 14 that physicians and other Part B providers receive a 1 percent increase in reimbursements in 2011.
The diagnostic imaging industry is likely to experience extensive consolidation in the new few years, predict leaders of the two largest imaging chains in the country, who hope to capitalize on acquisition opportunities.
The Food and Drug Administration (FDA) has given 510(k) approval to the Fuji Digital Radiography (FDR) AcSelerate system, making it available for sale in the United States.
The Centers for Medicare and Medicaid Services (CMS) said Jan. 22 that it has approved three organizations to accredit imaging suppliers.
The European picture archiving and communication system (PACS) market is expected to grow about 5.9 percent annually through 2015, reaching $848 million by 2015, says a new report from GlobalData, a market research firm.
GE Global Research, the technology development arm for General Electric, has been awarded a four-year, $3.27 million award from the National Institutes of Health (NIH) to develop new magnet technology that will make magnetic resonance imaging (MRI) systems less costly and easier to site.
Bayer Healthcare Pharmaceuticals (Wayne, N.J.) has settled a lawsuit involving a California man who allegedly contracted nephrogenic systemic fibrosis (NSF) after administration of the company’s Magnevist gadolinium-based MRI contrast agent.
The Food and Drug Administration (FDA) has sent notices of violation to GE Healthcare and Bracco Diagnostics for marketing claims related to their Visipaque and Isovue X-ray contrast agents.
The 10 stocks in the G-2 Reports’ Diagnostic Imaging Index rose by an unweighted average of 2 percent in the four weeks ended Jan. 22, 2010, with seven stocks rising in price and three falling.
Amid concerns over deployments of whole-body scanners at security checkpoints in airports, the American College of Radiology (ACR) has issued a statement noting that an airline passenger flying cross-country is exposed to more radiation from the flight than from screening by one of the scanners.
Diagnostic Imaging Intelligence Report is part of...
